You can buy or sell ALDX and other stocks, options, and ETFs commission-free!
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. Read More The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA. The listed name for ALDX is Aldeyra Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, Pre-Market